Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.

Current molecular medicine - 1 Jan 2014

Vanichakarn P, Hwa J, Stitham J

Abstract excerpt

Recent changes to the clinical management guidelines for hypertension and hyperlipidemia have placed emphasis on prevention through the pharmacological control and reduction of cardiovascular risk factors. In conjunction with proper diet and lifestyle changes, such risk factor control necessitates the use of safe and effective pharmacotherapy. However, many patients fail to reach or maintain therapeutic goals due...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Cardiovascular Diseases
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypolipidemic Agents

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Precision Medicine

Share to Risk Factors

Source

Identifiers

PMID: 25109793
DOI: 10.2174/1566524014666140811115517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.PMID 25109793Read ↗

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.Semantic proximity Read ↗

Cardiovascular pharmacogenomics and individualized drug therapy.Semantic proximity Read ↗

Pharmacogenetics of antihypertensive treatment.Semantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read ↗

[Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].Semantic proximity Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

The Future of Pharmacogenetics in the Treatment of HypertensionSemantic proximity Read ↗

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.Semantic proximity Read ↗

Genetic polymorphisms influencing antihypertensive drug responsesSemantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

When the same treatment has different response: The role of pharmacogenomics in statin therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.